Clin Exp Otorhinolaryngol.  2024 Feb;17(1):46-55. 10.21053/ceo.2024.00011.

Early Postoperative Benefits in Receptive and Expressive Language Development After Cochlear Implantation Under 9 Months of Age in Comparison to Implantation at Later Ages

Affiliations
  • 1Department of Otorhinolaryngology-Head and Neck Surgery, Ilsan Paik Hospital, Inje University College of Medicine, Goyang, Korea
  • 2Department of Otorhinolaryngology-Head and Neck Surgery, Seoul National University Bundang Hospital, Seongnam, Korea
  • 3Department of Otorhinolaryngology-Head and Neck Surgery, Chungnam National University Sejong Hospital, Chungnam National University College of Medicine, Sejong, Korea
  • 4Department of Otorhinolaryngology-Head and Neck Surgery, Seoul National University College of Medicine, Seoul, Korea
  • 5Sensory Organ Research Institute, Seoul National University Medical Research Center, Seoul, Korea

Abstract


Objectives
. The recent expansion of eligibility for cochlear implantation (CI) by the U.S. Food and Drug Administration (FDA) to include infants as young as 9 months has reignited debates concerning the clinically appropriate cut-off age for pediatric CI. Our study compared the early postoperative trajectories of receptive and expressive language development in children who received CI before 9 months of age with those who received it between 9 and 12 months. This study involved a unique pediatric cohort with documented etiology, where the timing of CI was based on objective criteria and efforts were made to minimize the influence of parental socioeconomic status.
Methods
. A retrospective review of 98 pediatric implantees recruited at a tertiary referral center was conducted. The timing of CI was based on auditory and language criteria focused on the extent of delay corresponding to the bottom 1st percentile of language development among age-matched controls, with patients categorized into very early (CI at <9 months), early (CI at 9–12 months) and delayed (CI at 12–18 months) CI groups. Postoperative receptive/expressive language development was assessed using the Sequenced Language Scale for Infants receptive and expressive standardized scores and percentiles.
Results
. Only the very early CI group showed significant improvements in receptive language starting at 3 months post-CI, aligning with normal-hearing peers by 9 months and maintaining this level until age 2 years. During this period (<2 years), all improvements were more pronounced in receptive language than in expressive language.
Conclusion
. CI before 9 months of age significantly improved receptive language development compared to later CI, with improvements sustained at least up to the age of 2. This study supports the consideration of earlier CI, beyond pediatric Food and Drug Administration labeling criteria (>9 months), in children with profound deafness who have a clear deafness etiology and language development delays (<1st percentile).

Keyword

Cochlear Implantation; Cochlear Implants; Sensorineural Hearing Loss; Language Development; Speech Disorder

Figure

  • Fig. 1. The overall number of patients at each age at implantation. The average age at cochlear implantation (CI) of our total pediatric cohort was 12.5±7.1 months. They were divided into three subgroups: < 9 months (very early CI group), 9–12 months (early CI group), and 12–18 months group (delayed CI group).

  • Fig. 2. Correlation analysis between Sequenced Language Scale for Infants (SELSI) receptive (A) and expressive (B) scores and age at implantation within the non-cochlear nerve deficiency patients demonstrated overall negative correlations at all postoperative time points. (C) Receptive scores at 24 months of age also indicated significantly negative correlations with younger ages at the time of implantation, while expressive scores did not. Postop, postoperative; CI, cochlear implant.


Reference

1. Food and Drug Administration. Summary of safety and effectiveness data (SSED): cochlear implant (CI) system [Internet]. Food and Drug Administration; 2020 [cited 2024 Feb 2]. Available from: https://www.accessdata.fda.gov/cdrh_docs/pdf/P970051S172B.pdf.
2. Food and Drug Administration. Drug safety communication: FDA approves label changes for use of general anesthetic and sedation drugs in young children [Internet]. Food and Drug Administration; 2017 [cited 2024 Feb 2]. Available from: https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-approves-label-changes-use-general-anesthetic-and-sedation-drugs.
3. Chweya CM, May MM, DeJong MD, Baas BS, Lohse CM, Driscoll CL, et al. Language and audiological outcomes among infants implanted before 9 and 12 months of age versus older children: a continuum of benefit associated with cochlear implantation at successively younger ages. Otol Neurotol. 2021; Jun. 42(5):686–93.
4. Leigh J, Dettman S, Dowell R, Briggs R. Communication development in children who receive a cochlear implant by 12 months of age. Otol Neurotol. 2013; Apr. 34(3):443–50.
5. Karltorp E, Eklof M, Ostlund E, Asp F, Tideholm B, Lofkvist U. Cochlear implants before 9 months of age led to more natural spoken language development without increased surgical risks. Acta Paediatr. 2020; Feb. 109(2):332–41.
6. Wie OB. Language development in children after receiving bilateral cochlear implants between 5 and 18 months. Int J Pediatr Otorhinolaryngol. 2010; Nov. 74(11):1258–66.
7. Naik AN, Varadarajan VV, Malhotra PS. Early pediatric cochlear implantation: an update. Laryngoscope Investig Otolaryngol. 2021; May. 6(3):512–21.
8. Chweya CM, Smith AJ, May MM, Lohse CM, Neff BA, Driscoll CL, et al. Prevalence of surgical, anesthetic, and device-related complications among infants implanted before 9 and 12 months of age versus older children: evidence for the continued expansion of pediatric cochlear implant candidacy criteria. Otol Neurotol. 2021; Jul. 42(6):e666–74.
9. Dettman S, Choo D, Au A, Luu A, Dowell R. Speech perception and language outcomes for infants receiving cochlear implants before or after 9 months of age: use of category-based aggregation of data in an unselected pediatric cohort. J Speech Lang Hear Res. 2021; Mar. 64(3):1023–39.
10. Culbertson SR, Dillon MT, Richter ME, Brown KD, Anderson MR, Hancock SL, et al. Younger age at cochlear implant activation results in improved auditory skill development for children with congenital deafness. J Speech Lang Hear Res. 2022; Sep. 65(9):3539–47.
11. Olsen LB, Larsen S, Wanscher JH, Faber CE, Jeppesen J. Postoperative infections following cochlear implant surgery. Acta Otolaryngol. 2018; Oct. 138(10):956–60.
12. Byun H, Moon IJ, Kim EY, Park J, Kwon SY, Han HD, et al. Performance after timely cochlear implantation in prelingually deaf children with cerebral palsy. Int J Pediatr Otorhinolaryngol. 2013; Jun. 77(6):1013–8.
13. Caragli V, Monzani D, Genovese E, Palma S, Persico AM. Cochlear implantation in children with additional disabilities: a systematic review. Children (Basel). 2023; Oct. 10(10):1653.
14. Suh MJ, Lee HJ, Choi HS. Early linguistic developments of simultaneous bilateral cochlear implantees. Korean J Otorhinolaryngol Head Neck Surg. 2018; Dec. 61(12):650–7.
15. Balasundaram P, Avulakunta ID. Bayley scales of infant and toddler development [Internet]. StatPearls Publishing; 2022 [cited 2024 Feb 2]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK567715/.
16. Kim YT. Content and reliability analyses of the Sequenced Language Scale for Infants (SELSI). Commun Sci Disord. 2002; 7(2):1–23.
17. Kim YT, Hong GH, Kim KH. Content and reliability analyses of the receptive and expressive vocabulary test (REVT). Commun Sci Disord. 2009; 14(1):34–45.
18. Moon IJ, Kim EY, Chu H, Chung WH, Cho YS, Hong SH. A new measurement tool for speech development based on Ling’s stages of speech acquisition in pediatric cochlear implant recipients. Int J Pediatr Otorhinolaryngol. 2011; Apr. 75(4):495–9.
19. Han MJ, Min JH, Kim SJ. Effect of oxcarbazepine on language function in patients with newly diagnosed pediatric epilepsy. J Clin Neurol. 2023; Jan. 19(1):76–82.
20. Yoon JA, An SW, Choi YS, Seo JS, Yoon SJ, Kim SY, et al. Correlation of language assessment batteries of toddlers with developmental language delay. Ann Rehabil Med. 2022; Oct. 46(5):256–62.
21. Min BJ, Kim N, Chung T, Kim OH, Nishimura G, Chung CY, et al. Whole-exome sequencing identifies mutations of KIF22 in spondyloepimetaphyseal dysplasia with joint laxity, leptodactylic type. Am J Hum Genet. 2011; Dec. 89(6):760–6.
22. Han KH, Kim AR, Kim MY, Ahn S, Oh SH, Song JH, et al. Establishment of a flexible real-time polymerase chain reaction-based platform for detecting prevalent deafness mutations associated with variable degree of sensorineural hearing loss in Koreans. PLoS One. 2016; Sep. 11(9):e0161756.
23. Lee SY, Oh DY, Han JH, Kim MY, Kim B, Kim BJ, et al. Flexible realtime polymerase chain reaction-based platforms for detecting deafness mutations in Koreans: a proposed guideline for the etiologic diagnosis of auditory neuropathy spectrum disorder. Diagnostics (Basel). 2020; Sep. 10(9):672.
24. Kim BJ, Kim AR, Lee C, Kim SY, Kim NK, Chang MY, et al. Discovery of CDH23 as a significant contributor to progressive postlingual sensorineural hearing loss in Koreans. PLoS One. 2016; Oct. 11(10):e0165680.
25. Kim Y, Han JH, Yoo HS, Choi BY. Molecular aetiology of ski-slope hearing loss and audiological course of cochlear implantees. Eur Arch Otorhinolaryngol. 2022; Oct. 279(10):4871–82.
26. Choi BY, Park G, Gim J, Kim AR, Kim BJ, Kim HS, et al. Diagnostic application of targeted resequencing for familial nonsyndromic hearing loss. PLoS One. 2013; Aug. 8(8):e68692.
27. Kim NK, Kim AR, Park KT, Kim SY, Kim MY, Nam JY, et al. Whole-exome sequencing reveals diverse modes of inheritance in sporadic mild to moderate sensorineural hearing loss in a pediatric population. Genet Med. 2015; Nov. 17(11):901–11.
28. Deep NL, Purcell PL, Gordon KA, Papsin BC, Roland JT Jr, Waltzman SB. Cochlear implantation in infants: evidence of safety. Trends Hear. 2021; Jan-Dec. 25:23312165211014695.
29. Hoff S, Ryan M, Thomas D, Tournis E, Kenny H, Hajduk J, et al. Safety and effectiveness of cochlear implantation of young children, including those with complicating conditions. Otol Neurotol. 2019; Apr. 40(4):454–63.
30. Miyamoto RT, Colson B, Henning S, Pisoni D. Cochlear implantation in infants below 12 months of age. World J Otorhinolaryngol Head Neck Surg. 2018; Feb. 3(4):214–8.
31. Roland JT Jr, Cosetti M, Wang KH, Immerman S, Waltzman SB. Cochlear implantation in the very young child: long-term safety and efficacy. Laryngoscope. 2009; Nov. 119(11):2205–10.
32. Dettman S, Choo D, Dowell R. Barriers to early cochlear implantation. Int J Audiol. 2016; 55 Suppl 2:S64–76.
33. Tait ME, Nikolopoulos TP, Lutman ME. Age at implantation and development of vocal and auditory preverbal skills in implanted deaf children. Int J Pediatr Otorhinolaryngol. 2007; Apr. 71(4):603–10.
34. Dunn CC, Walker EA, Oleson J, Kenworthy M, Van Voorst T, Tomblin JB, et al. Longitudinal speech perception and language performance in pediatric cochlear implant users: the effect of age at implantation. Ear Hear. 2014; Mar-Apr. 35(2):148–60.
35. Park JH, Kim AR, Han JH, Kim SD, Kim SH, Koo JW, et al. Outcome of cochlear implantation in prelingually deafened children according to molecular genetic etiology. Ear Hear. 2017; Sep/Oct. 38(5):e316–24.
Full Text Links
  • CEO
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr